ReviewJournal of leukocyte biology2021

BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.

Michael C McGee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.